Brief: Cereno Scientific Gets Patent Approval In Australia
March 7 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC RECEIVES PATENT APPROVAL IN AUSTRALIA
FOR USE
OF DRUG CANDIDATE CS1
* AUSTRALIAN PATENT WILL BE VALID THROUGH 2032, WITH
POSSIBILITY
OF A PATENT EXTENSION OF AN ADDITIONAL FIVE YEAR MAXIMUM.
Source text for Eikon: ID:nWkr3Lmm6q
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global